Investors and Media

Idera Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel nucleic acid-based therapies for the treatment of certain cancers and rare diseases.

Recent News

Feb 06, 2017Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early DevelopmentRead MoreJan 04, 2017Idera to Present at the 35th Annual J.P. Morgan Healthcare ConferenceRead MoreNov 28, 2016Idera Pharmaceuticals and Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement for the Worldwide Rights to IMO-9200Read More

Upcoming Events

There are currently no events scheduled.


January 09, 2017
2017 JP Morgan Healthcare Conference Presentation
Data provided by Nasdaq. Minimum 15 minutes delayed.